HK HIS
資料室
専門資料
> 資料 > 専門資料

免疫治療 | 転移性メラノーマ患者のLN-145の免疫治療のための臨床募集

페이지 정보

作成者 HK HIS 作成日19-09-16 18:21 照会343回 コメント0回

본문

A Phase 2, Multicenter Study to Assess the Efficacy and Safety of Autologous Tumor Infiltrating Lymphocytes (LN-144) for Treatment of Patients with Metastatic Melanoma.


HK health information service|香港現地住所(Room 1405, 14/F., Austin Tower,22-26 Austin Avenue,Tsim Sha Tsui, Kowloon,Hong Kong)
電話 : 860769-38856750|ファクス : 860769-38851107|Email : consult@hkhis.hk
COPYRIGHT 2019 ⓒ hkhis.hk. ALL RIGHTS RESERVED. DESIGNED BY WEPAS